Gene detection products that analyze drug metabolism and efficacy based on individual genetic variations. These tests guide personalized medication selection for patients with cardiovascular and other major diseases.
Manufactured by
China
YZY Medical is a high-tech enterprise specializing in personalized molecular diagnostics for cardiovascular and oncology applications. The company has developed 160+ genetic diagnostic products and multiple IVD devices, with 14 molecular diagnostic kits holding NMPA Class III registration. Technical platforms include ARMS qPCR, multiplex qPCR, mass spectrometry, FISH, and circulating tumor cell detection. The company operates a 2,000 sqm R&D center and 3,200 sqm GMP production facility with ISO13485:2016 and CE certifications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Cygnus Biosciences (Beijing)Co., Ltd.
China · 2 relevant products
LYTECH
Serbia · 2 relevant products
HymonBio Co., Ltd.
China · 3 relevant products
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →17 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 96 closest product alternatives
Cygnus Biosciences (Beijing)Co., Ltd. · China
This product performs genetic testing of drug-related genes related to common psychiatric and neuropsychiatric disorders to provide medication guidance for clinical diagnosis and treatment.
LYTECH · Serbia
Genetic polymorphism detection kits for identifying genetic variations associated with drug metabolism, disease susceptibility, and therapeutic response. These in vitro diagnostic kits enable clinicians to personalize treatment decisions based on individual genetic profiles, supporting pharmacogenomics and precision medicine applications in clinical laboratories.
HymonBio Co., Ltd. · China
In vitro diagnostic kit for detecting metabolic enzyme gene polymorphisms to assess individual drug metabolism capacity and guide personalized medication therapy. Uses molecular analysis to identify genetic variants affecting cytochrome P450 and other metabolic enzymes, enabling clinicians to optimize drug selection and dosing based on patient pharmacogenetic profiles.
93 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products